SEC Tracker
Get the app

Pacira BioSciences PCRX

Pacira BioSciences announces tender offer

Tender offer response

Form
Schedule 14D9
Filed
Importance
Notable
  1. Pacira has 39,957,678 shares outstanding as of Oct 23, 2026
  2. Viatris offers $36.50 per share for Pacira's stock
  3. The tender offer expires on Nov 16, 2026
  4. Pacira's shares are subject to conversion from convertible notes

Written from the Schedule 14D9 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Pacira BioSciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  2. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025
  3. Geron GERN public float $861M, Jun 30, 2025
  4. Anaptysbio ANAB public float $633M, Dec 31, 2025
  5. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025